Henry I. "Hank" Yamamura, an eminent neuropharmacologist, died September 4, 2008, after a long struggle with cancer. Even while ill, he continued his research and scholarly activities.

Dr. Yamamura pioneered radioligand binding assays, contributing valuable knowledge about neurotransmitter transporters and muscarinic, opioid, and other G-protein-coupled receptors. He published more than 600 articles and edited 10 books. He received numerous awards including the American Society for Pharmacology and Experimental Therapeutics (ASPET) Award for Experimental Therapeutics in 1995.
Born in Seattle in 1940, Dr. Yamamura obtained a B.S. in pharmacy and a Ph.D. in pharmacology at the University of Washington. He was a captain in the Army Medical Service Corps (1970-1973) and then a postdoctoral fellow with Sol Snyder at Johns Hopkins University. He joined the Pharmacology Department at the University of Arizona College of Medicine in 1975 and spent the rest of his career there. He held joint appointments in the departments of psychiatry and biochemistry and in 1997 was named Regents Professor in the College of Medicine. He trained and mentored more than 100 students, fellows, and visiting faculty.
Categories
Tags
Drug Topics
Drugs of Abuse
Population Groups
Related Topics
Attention
Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at
Looking for Treatment?
Use the SAMHSA Treatment Locator or 1-800-662-HELP.
Helpline open during government shutdown

